Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions
Conditions: Coronary Artery Disease; Diabetes Mellitus; Percutaneous Coronary Intervention Interventions: Drug: Empagliflozin 10Mg Tab; Drug: hypoglycemic therapy Sponsor: Research Institute for Complex Problems of Cardiovascular Diseases, Russia Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Empagliflozin | Endocrinology | Heart | Jardiance | Research | Russia Health